FDA Approved: EPOPROSTENOL — Original Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved the generic epoprostenol injection from Mylan Institutional LLC under an Original Application; epoprostenol is used to treat pulmonary arterial hyp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Epoprostenol (Epoprostenol)

Snippet

ORIG AP for EPOPROSTENOL (EPOPROSTENOL)